whatpeptidestostackSelank and Semax
Co-studiedTwo neuroactive peptides measured in one brain-imaging study, in separate groups. Measured together is not the same as given together.
How the two mechanisms relate
This part is our reading of the mechanism. The grade above is what the published record shows.
What this pairing does and does not show
"Co-studied" means both compounds showed up in one study without being combined. Here it was a brain-imaging study, with Selank and Semax in separate groups, so nobody got both.
There's no combined dose or outcome on record for the pair.
Each has its own thin record. Selank has two small randomized trials in anxiety disorders reporting improvement; the rest is animal or lab work. Semax evidence is mostly animal, with small human imaging studies and one combined-procedure study.
The Selank and Semax profiles link each study, and the cognition and mood goal shows where both sit.
The compounds
Selank
A heptapeptide studied for anxiety. Two small randomized trials in anxiety disorders report improvement, and the rest of the evidence is animal or laboratory work.
Full profile, dosing and safety →Semax
A heptapeptide studied for cognition and neuroprotection. The outcome evidence is mostly animal, and the human records are small imaging studies and one combined-procedure study.
Full profile, dosing and safety →